Publication

Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia

Amansyah F., Putra A., Rachmad B., Retnaningsih R., Widyatmoko A., Amansyah F., Ibrahim S., Pasongka Z., Sari F.E., Berlian M.A.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the outbreak of coronavirus disease 2019 (COVID-19), which has been rapidly spreading. Several guideline therapies have been proposed as a possible treatment for SARS-CoV-2, however, these therapies are not sufficient to treat a severe condition of SARS-CoV-2 infection characterised by the increase of D-dimer and C-reactive protein (CRP) levels, and patchy ground-glass opacities (GGOs). Secretome-mesenchymal stem cells (S-MSCs) produced by MSCs under hypoxia could excessively release several anti-inflammatory cytokines and growth factors to control the COVID-19 cytokine storm and accelerate lung injury improvement. This is the first study investigating the clinical outcomes of three severe COVID-19 patients admitted to the intensive care unit of three different hospitals in Indonesia treated with S-MSCs. The decrease of D-dimer and CRP level was reported for all patients treated with S-MSCs. This was in line with improvement of pulmonary radiology, blood gas level, and hematologic assessment. In conclusion, these cases suggest that S-MSCs could effectively control D-dimer, CRP level and GGOs of severe COVID-19 patients associated with recovered pulmonary function.

Journal

F1000research

Page Range

Publication date

2021

Total citations

Cited by 12

IL-10 attenuates TNF-α-induced NFκB pathway activation and cardiomyocyte apoptosis

Arora R.C., Arora R.C., Dhingra S., Dhingra S., Sharma A.K., Sharma A.K., Singal P.K., Singal P.K., Slezak J.

Endothelial progenitor cells promote viability and nerve regenerative ability of mesenchymal stem cells through PDGF-BB/PDGFR-β signaling

Chen T., Chen Z., Fang J., Han X., Hu C., Huang X., Ouyang X., Wei H., Yang X., Zheng Z.

Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling

Banasr M., Duman R.S., Elsayed M., Fournier N.M., Lee B.

Mesenchymal stem cell secretome as an emerging cell-free alternative for improving wound repair

Ahangar P., Cowin A.J., Mills S.J., Ahangar P., Cowin A.J., Mills S.J., Ahangar P., Cowin A.J., Mills S.J., Ahangar P., Cowin A.J., Mills S.J., Ahangar P., Cowin A.J., Mills S.J.

MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC

Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A.

The role of tnf-α induced mscs on suppressive inflammation by increasing tgf-β and il-10

Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K.

Macrophage activation syndrome and COVID-19

Otsuka R., Seino K.-I.

The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19

Gao S.-D., Huang L.-G., Lai Q.-N., Li T., Luo Y.-J., Lv X.-L., Mo Q., Sun H.-B., Wang T., Wang Z.-K., Xu J.-S., Ye X.-Z., Zhang Y.-M., Zhu H.-H., Zhu Z.-Z.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Chen N., Dong X., Gong F., Han Y., Han Y., Liu Y., Qiu Y., Qu J., Wang J., Wei Y., Xia J., Yu T., Zhang L., Zhang X., Zhou M., Chen N., Dong X., Gong F., Han Y., Han Y., Liu Y., Qiu Y., Qu J., Wang J., Wei Y., Xia J., Yu T., Zhang L., Zhang X., Zhou M.